macimorelin: Clinical Trials

6 trials of macimorelin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 3 Phase 3, 1 Not applicable, 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Completed 3
Not applicable1Completed 1
Phase 11Completed 1
Phase 21Completed 1

Follow macimorelin: new trials by email Literature Review of macimorelin trials Research Report on macimorelin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Research Study of How Well Macimorelin Works to Find Out if Children Have a Lack of Growth Hormone and How Safe it is
Macimorelin, Arginine, Clonidine - Growth Hormone Deficiency
Phase 3CompletedAEterna Zentaris1012021-11-162024-08-12
Copeptin After an Oral Stimulation With Macimorelin in Healthy Volunteers
Macimorelin 0.5mg/kg body weight, Macimorelin 0.75mg/kg body weight - Polyuria-polydipsia Syndrome
Not applicableCompletedUniversity Hospital, Basel, Switzerland282019-03-072019-08-08
Validation of Macimorelin as a Test for Adult Growth Hormone Deficiency
Macimorelin, Insulin - Growth Hormone Deficiency With Pituitary Anomalies
Phase 3CompletedAEterna Zentaris1572015-12-032018-04-10
Pilot Clinical Trial of Repeated Doses of Macimorelin to Assess Safety and Efficacy in Patients With Cancer Cachexia
Macimorelin, Placebo - Cancer Cachexia
Phase 2CompletedGarcia, Jose M., MD, PhD152012-05-012024-03-20
Investigation of a New, Oral Growth Hormone Secretagogue, AEZS-130 as a Growth Hormone Stimulation Test.
AEZS-130 (formerly ARD-07), L-ARG+GHRH - Diagnosis of Adult Growth Hormone Deficiency (AGDH)
Phase 3CompletedAEterna Zentaris1012007-06-012019-07-23
Oral Ghrelin Agonist in Healthy Subjects
EP1572 (ghrelin agonist) oral and duodenal application - Healthy Subjects
Phase 1CompletedUniversity Hospital, Basel, Switzerland422005-11-012007-05-03

Conditions studied

Dwarfism, Pituitary (2)  ·  Diabetes Insipidus (1)  ·  Growth Hormone Deficiency With Pituitary Anomalies (1)

Sponsors

AEterna Zentaris (3)  ·  University Hospital, Basel, Switzerland (2)  ·  Garcia, Jose M., MD, PhD (1)

Countries

United States (4)  ·  Germany (2)  ·  Italy (2)  ·  Poland (2)  ·  Serbia (2)  ·  Armenia (1)  ·  Austria (1)  ·  France (1)  ·  Georgia (1)  ·  Romania (1)  ·  Slovakia (1)  ·  Slovenia (1)  ·  Spain (1)  ·  Switzerland (1)  ·  Turkey (Türkiye) (1)

Top investigators

Beverly MK Biller, MD (1)  ·  Christoph Beglinger (1)  ·  Jose M Garcia, MD PhD (1)  ·  Jose M Garcia, MD, PhD (1)  ·  Mirjam Christ-Crain, Prof. Dr. MD (1)  ·  Nicola K Ammer, MD (1)

Results publications

PMID 17284637, PMID 23559086, PMID 29575771, PMID 29860473, PMID 33615399, PMID 36860137

NIH funding

2018 (2), 2015 (1)